Word

MORFFI

Status

Registered

Status Code

700

Status Date

Tuesday, October 9, 2018

Serial Number

87222158

Registration Number

5578007

Registration Date

Tuesday, October 9, 2018

Mark Type

4000

Filing Date

Tuesday, November 1, 2016

Published for Opposition

Tuesday, January 16, 2018

Trademark Owner History

BBI Solutions OEM Limited - Original Registrant

Classifications

40 Custom manufacturing services of goods relating to conjugate blocking technology; custom manufacturing services of goods relating to assays and lateral flow assays and enhancement and performance of lateral flow assays

5 Chemicals and chemical reagents for medical use; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical and medical diagnostic purposes; reagents in kit form for performing assays for diagnostic and medical purposes; diagnostic reagents for diagnostic and medical use; proteins for diagnostic and medical use; cell culture proteins for diagnostic and medical use; monoclonal antibodies for diagnostic and medical use; enzymes for diagnostic and medical use; albumin for diagnostic and medical use; human and animal blood plasma; chemicals agents for use in separation for diagnostic and medical use; cell culture media for use in separation techniques for diagnostic and medical use

1 Chemical products in the nature of chemicals for use in industry and science; chemicals and chemical reagents for non-medical laboratory use; chemicals, reagents, immunoassay preparations and substances for testing blood, bodily fluids samples, antibodies and purified agents for diagnostic purposes; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; reagents in kit form for performing assays for scientific and research use; chemical substances and immunoassays in the nature of assays for use in diagnostic kits for research purposes; diagnostic reagents for scientific and research use; exogenous antigen, endogenous antigen and autoantigen agents for activating cellular functions; proteins for scientific and research use; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; cell culture proteins for scientific and research use; monoclonal antibodies for in vitro scientific and research use; antigens, namely, exogenous antigens, endogenous antigens, and autoantigens for scientific and medical research use; enzymes for in vitro, scientific, and research use; transferrin, namely, glycoproteins; albumin for scientific and research purposes; human antigens, namely, exogenous antigens, endogenous antigens, and autoantigens for scientific and medical research use; human and animal plasma for scientific and medical research use; human and animal serum, namely, albumin and bovine serum for scientific and medical research use; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; chemicals and chemical reagents for diagnostic laboratory use

42 Scientific and technological development services and research and design relating thereto in the field of lateral flow immunoassays and conjugate blocking technology; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; scientific and technological services, namely, design and research relating to lateral flow conjugation processes; scientific and technological services, namely, design and research relating to the enhancement and performance of lateral flow assays; industrial analysis and research services for the enhancement and performance of lateral flow assays; diagnostic and medical laboratory services; chemical analysis and research for others; diagnostic medical testing for medical, scientific and research purposes; diagnostic medical testing relating to assays for diagnostic, medical and research purposes; diagnostic medical testing relating to conjugate blocking technology for diagnostic, medical, scientific and technological purposes; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for the diagnostics industry; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; research and analysis for the diagnostics industry; technological services, namely, reading of results, processing of results, technical information, data sheets, and brochures relating to assays and lateral flow assays; technological and scientific research services relating to assays and lateral flow assays; lateral flow development of assays and lateral flow diagnostic testing services for medical, scientific and research purposes; development of lateral flow assays, lateral flow immunoassays and research into conjugate blocking technology; advisory, information and consultancy services relating to all of the aforesaid

Trademark Events

Oct 9, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Oct 9, 2018

Registered-Principal Register

Aug 30, 2018

1(B) Basis Deleted; Proceed To Registration

Jul 17, 2018

Notice Of Allowance Cancelled

Aug 30, 2018

Case Assigned To Intent To Use Paralegal

Jul 17, 2018

Teas Delete 1(B) Basis Received

Mar 13, 2018

Noa E-Mailed - Sou Required From Applicant

Jan 16, 2018

Official Gazette Publication Confirmation E-Mailed

Jan 16, 2018

Published For Opposition

Dec 27, 2017

Notification Of Notice Of Publication E-Mailed

Dec 8, 2017

Approved For Pub - Principal Register

Dec 7, 2017

Teas/Email Correspondence Entered

Dec 7, 2017

Correspondence Received In Law Office

Dec 7, 2017

Teas Request For Reconsideration Received

Oct 24, 2017

Notification Of Final Refusal Emailed

Oct 24, 2017

Final Refusal E-Mailed

Oct 24, 2017

Final Refusal Written

Sep 7, 2017

Teas/Email Correspondence Entered

Sep 7, 2017

Correspondence Received In Law Office

Sep 1, 2017

Teas Voluntary Amendment Received

Aug 28, 2017

Teas/Email Correspondence Entered

Aug 28, 2017

Correspondence Received In Law Office

Aug 24, 2017

Assigned To Lie

Aug 4, 2017

Teas Response To Office Action Received

Feb 9, 2017

Notification Of Non-Final Action E-Mailed

Feb 9, 2017

Non-Final Action E-Mailed

Feb 9, 2017

Non-Final Action Written

Feb 8, 2017

Assigned To Examiner

Nov 4, 2016

New Application Office Supplied Data Entered

Nov 4, 2016

New Application Entered